- Home
- ABEO vs ANPA Comparison
ABEO vs ANPA Comparison
Compare ABEO & ANPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | ANPA |
|---|---|---|
| Founded | 1974 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 300.0M |
| IPO Year | 1980 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ABEO | ANPA |
|---|---|---|
| Price | $5.06 | $23.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $18.20 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 15.0K |
| Earning Date | 11-12-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | 0.06 |
| Revenue | $400,000.00 | ★ $5,832,684.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,590.36 | N/A |
| P/E Ratio | ★ $4.17 | $299.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.93 | $2.80 |
| 52 Week High | $7.54 | $54.75 |
Technical Indicators
Market Signals| Indicator | ABEO | ANPA |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | N/A |
| Support Level | $4.53 | N/A |
| Resistance Level | $5.61 | N/A |
| Average True Range (ATR) | 0.27 | 0.00 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 49.30 | 0.00 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About ANPA Rich Sparkle Holdings Limited Ordinary Shares
Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.